KDC-MN-393 – Kodiac biolabs

Plain-language summaryIntrigue 52 / 100

Nandrolone (19-nortestosterone) is the parent of an entire class of anabolic steroids defined by the missing 19-carbon. That single deletion does two useful things: it reduces aromatization to estrogen and it prevents 5-alpha-reduction from making a more potent metabolite. Instead, 5-alpha-reduction in skin and other tissues yields dihydronandrolone, which has lower AR affinity than the parent, so androgenic side effects are blunted. The decanoate ester (Deca-Durabolin) gives a 14-day half-life IM; phenylpropionate is faster (3 to 4 days). Approved for anemia of kidney disease and historically for osteoporosis. Schedule III. Heavy non-medical use in bodybuilding for lean mass and (anecdotally) joint support. Sexual dysfunction with prolonged use is attributed to progestogenic metabolites. Canonical 19-nor AAS. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Our opinion on this compoundEstablished workhorse

45/100

Canonical 19-nor AAS with real reference probe value but no research frontier left to explore

Look, the nandrolone story is genuinely elegant in places, just not in places that matter for a 2025 research agenda. First synthesized in the late 1950s, esterified into Deca-Durabolin by the early 1960s, approved for anemia of chronic kidney disease and historically for osteoporosis. The pharmacology has a neat mechanistic inversion at its core: 5-alpha-reduction of nandrolone produces dihydronandrolone, which carries lower AR affinity than the parent compound. Thats the opposite of the testosterone-to-DHT relationship. The result is tissue-selective anabolism, reduced androgenic expression in tissues dominated by 5-alpha-reductase activity, and a dissociation profile that made 19-nortestosterone derivatives attractive for clinical development in the first place.

But elegant and worked-out-decades-ago are the same thing here. The mechanistic picture is in every AAS pharmacology review going back to the 1970s. The approved-drug status gives nandrolone genuinely solid translational signal, multiple regulatory approvals, and a pharmacokinetic profile that’s been characterized across ester formulations (decanoate at roughly a 14-day half-life, phenylpropionate at 3 to 4 days). That’s a meaningful advantage when you need rigorous comparators or a well-characterized 19-nor AAS in an experimental design. It’s just not a signal pointing at anything new.

The progestogenic activity angle is the most underexplored piece of the puzzle. The so-called deca dick phenomenon, attributed to progestogenic metabolites suppressing the HPG axis and competing at androgen-sensitive circuits in sexual function, is a legitimate research question that hasn’t been fully characterized in clean mechanistic terms. If your program is studying the intersection of progestogenic and androgenic signaling in reproductive neuroendocrinology, nandrolone is the reference compound. There’s no substitute as a canonical 19-nor probe in that specific context.

Outside that niche, we think the bench case for nandrolone as a primary investigation target is weak. The active research community working on tissue-selective anabolism has largely migrated toward SARMs with better selectivity windows and cleaner receptor profiles. The GLP-1 and peptide fields have absorbed the metabolic-anabolic interest. Nandrolone is competing against a much richer pharmacological toolkit and losing on novelty at every turn.

What keeps it off the bottom of the library is exactly that reference utility. Approved drug, well-characterized PK, canonical class membership, real translational signal. If you need a 19-nor AAS in your experiment, this is the compound. Honestly, thats a real but narrow claim, and the score reflects it.

Novelty: 18
Mechanism promise: 40
In-category differentiation: 40
Evidence quality: 65
Translational signal: 68
Research bench value: 55

Rationale Schedule III cap (75) does not bind since the weighted score lands at 45 on its own merits. Nandrolone scores well on evidence and translational signal because it is an approved drug with decades of clinical data, but novelty is near-floor and the mechanism has been fully characterized for 40-plus years; the residual value is as a canonical reference compound for 19-nor AR pharmacology, not as a primary investigation target.

19-nortestosterone (parent of nandrolone class)

19-nortestosterone; the parent compound of the nandrolone class of AAS; the decanoate ester is approved for anemia and osteoporosis.

Abstract

Nandrolone (17-beta-hydroxyestr-4-en-3-one; CAS 434-22-0; molecular formula C18H26O2; molecular weight 274.40) is the parent compound of the 19-nortestosterone (nandrolone) class of AAS; the 19-nor modification reduces aromatization to estrogen and prevents 5-alpha-reduction to a more potent metabolite. The compound itself binds AR with affinity approximately 5-fold higher than testosterone but with reduced effects in some tissues (5-alpha-reduction by 5-AR produces dihydronandrolone, which has lower AR affinity than nandrolone, in contrast to testosterone-DHT relationship; the result is reduced androgenic side effects). The decanoate ester (Deca-Durabolin) provides a 14-day half-life for IM administration; the phenylpropionate ester provides a shorter (3 to 4 day) half-life. Approved for anemia of chronic kidney disease and (historically) osteoporosis. Schedule III. Widely used in non-medical bodybuilding for lean mass gains and (anecdotally) joint support. The “deca dick” sexual dysfunction is attributed to the progestogenic activity of nandrolone metabolites. Used as the canonical 19-nor AAS in research.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, sourcing and quality verification, and a curated reference list. Embedded inline below; download for offline reading.

KDC-MN-393Open in new tab →

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Tag: KDC-MN-393

Nandrolone

Abstract

Read the full monograph